|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net loss from consolidated operations | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Goodwill impairment loss | |||||
| Equity-based compensation | |||||
| Depreciation and amortization | |||||
| Provision (adjustment) for credit losses | |||||
| Noncash lease expense | |||||
| (Gain) loss on disposal of fixed asset | |||||
| Discount premium of marketable securities | |||||
| Deferred taxes | |||||
| Unrecognized tax benefits | |||||
| Net realized (gain) loss on marketable securities | |||||
| Impairment of available-for-sale debt securities | |||||
| Impairment loss | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Trade accounts receivable | |||||
| Income tax | |||||
| Other current and long-term assets | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Customer deposits | |||||
| Accrued liabilities and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flow from investing activities: | |||||
| Purchase of marketable securities | |||||
| Purchases of fixed assets | |||||
| Maturities of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from sale of fixed assets | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flow from financing activities: | |||||
| Common stock withholding for employee tax obligations | |||||
| Re-payment for the margin account | |||||
| Repayment of notes payable | |||||
| Principal paid for finance lease | |||||
| Repurchase of common stock | |||||
| Repayment of investment margin loan | |||||
| Proceeds from exercise of stock options | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Supplemental disclosures of cash flow information: | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Contingent consideration for business acquisition included in additional paid-in capital | |||||
| Purchases of fixed assets in accounts payable | |||||
| Holdback for acquisition of business included in other long-term liabilities | |||||
| Operating lease right-of-use assets obtained in exchange for lease liabilities | |||||
| Finance lease right-of-use assets reduced due to lease modification or termination | |||||
| Operating lease right-of-use assets reduced due to lease modification and termination | |||||
| Operating lease liabilities removed due to purchasing underlying assets | |||||
| Finance lease right-of-use assets reduced due to lease modification and termination | |||||
Loading...